Literature DB >> 222788

Tumorigenicity of cells transformed by Simian virus 40 and of hybrids between such cells and normal diploid cells.

C J Gee, H Harris.   

Abstract

A number of newly isolated clonal cell lines derived from diploid mouse embryo cells transformed by SV40 were examined in vitro and in vivo. Although these lines showed the properties that define transformation in vitro, they were not tumorigenic for many passages after their initial isolation. Cells from tumours eventually produced by the SV40-transformed cells were fused with diploid mouse embryo cells. The hybrids formed were initially non-tumorigenic. This indicates that a normal diploid cell can suppress the malignant phenotype of a tumorigenic SV40-transformed cell. The hybrid cells did, however, express the SV40 T antigen and they nad a clearly transformed phenotype in vitro. It thus appears that neither the transformed phenotype nor the expression of the SV40 T antigen are enough to endow a cell with the ability to grow progressively in vivo. The relationship between the transformed phenotype and tumorigenicity was further studied by fusing malignant mouse melanoma cells with non-tumorigenic SV40-transformed cells. The hybrids expressed the transformed phenotype in vitro but unable to form tumours in vivo. The changes that occur in cells after transformation by SV40 do not apparently affect the ability of these cells to suppress the malignant phenotype of tumour cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222788     DOI: 10.1242/jcs.36.1.223

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  13 in total

1.  Intermediate filament expression and lifespan potential in human somatic cell hybrids.

Authors:  C L Bunn; F A White; W M O'Guin; R H Sawyer; L W Knapp
Journal:  In Vitro Cell Dev Biol       Date:  1985-12

Review 2.  The immunopathology of SV40-induced transformation.

Authors:  P T Mora
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Chemical carcinogens transform BHK cells by inducing a recessive mutation.

Authors:  N Bouck; G di Mayorca
Journal:  Mol Cell Biol       Date:  1982-02       Impact factor: 4.272

4.  The majority of independently transformed BHK cell clones share a single functional lesion which determines anchorage independence and influences tumorigenicity.

Authors:  N Bouck; M Head
Journal:  In Vitro Cell Dev Biol       Date:  1985-08

Review 5.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Recombination and its roles in DNA repair, cellular immortalization and cancer.

Authors:  M A Shammas; R J Shmookler Reis
Journal:  Age (Omaha)       Date:  1999-04

7.  Bone morphogenetic protein-9 effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papilla.

Authors:  Jinhua Wang; Hongmei Zhang; Wenwen Zhang; Enyi Huang; Ning Wang; Ningning Wu; Sheng Wen; Xian Chen; Zhan Liao; Fang Deng; Liangjun Yin; Junhui Zhang; Qian Zhang; Zhengjian Yan; Wei Liu; Zhonglin Zhang; Jixing Ye; Youlin Deng; Hue H Luu; Rex C Haydon; Tong-Chuan He; Feng Deng
Journal:  Stem Cells Dev       Date:  2014-03-21       Impact factor: 3.272

8.  Suppression of malignancy in human cancer cells: issues and challenges.

Authors:  A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  Establishment and characterization of the reversibly immortalized mouse fetal heart progenitors.

Authors:  Mi Li; Yuan Chen; Yang Bi; Wei Jiang; Qing Luo; Yun He; Yuxi Su; Xing Liu; Jing Cui; Wenwen Zhang; Ruidong Li; Yuhan Kong; Jiye Zhang; Jinhua Wang; Hongyu Zhang; Wei Shui; Ningning Wu; Jing Zhu; Jie Tian; Qi-Jian Yi; Hue H Luu; Rex C Haydon; Tong-Chuan He; Gao-Hui Zhu
Journal:  Int J Med Sci       Date:  2013-06-20       Impact factor: 3.738

10.  Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome.

Authors:  J Pal; R Bertheau; L Buon; A Qazi; R B Batchu; S Bandyopadhyay; R Ali-Fehmi; D G Beer; D W Weaver; R J Shmookler Reis; R K Goyal; Q Huang; N C Munshi; M A Shammas
Journal:  Oncogene       Date:  2011-03-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.